Qini Curves for Potential Impact Assessment of Risk Predictive Models Informing Intervention Policies.

IF 6 2区 医学 Q1 ECONOMICS Value in Health Pub Date : 2025-02-13 DOI:10.1016/j.jval.2025.01.024
Pierpaolo Palumbo
{"title":"Qini Curves for Potential Impact Assessment of Risk Predictive Models Informing Intervention Policies.","authors":"Pierpaolo Palumbo","doi":"10.1016/j.jval.2025.01.024","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Predictive models in medicine help make decisions about which individual to treat with a given therapeutic or preventive intervention. Before being tested in large field studies and recommended for clinical adoption, it is important to evaluate not only their statistical accuracy but also the impact they may have when used to inform health intervention policies. We aim to provide simple methods for the potential impact assessment of health intervention policies based on predictive models.</p><p><strong>Methods: </strong>We propose an analytic framework based on Qini curves wherein prediction-based policies are analyzed on 2 impact endpoints: (1) the fraction of the population that would be selected for the intervention (coverage) and (2) the effect on the clinical outcomes of interest (disutility). The drivers of values are the disease prevalence, the predictive performance of the model, and the effectiveness of the intervention.</p><p><strong>Results: </strong>We present simple formulas for calculating coverage and disutility from either observational or randomized controlled data. We illustrate possible value measures arising from geometrical properties on the Qini plane: delta coverage and disutility, number needed to treat, and integrated difference between Qini curves. We show the applicability of the Qini analysis by providing examples about the prevention of falls in older adults and prevention of secondary cardiovascular events with pioglitazone.</p><p><strong>Conclusions: </strong>Coverage and disutility capture key value components of prediction-based policies. The method can be used for comparing models or tuning risk thresholds for managing trade-offs between conflicting objectives (eg, clinical benefits, side effects, and healthcare resources).</p>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":" ","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Value in Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jval.2025.01.024","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Predictive models in medicine help make decisions about which individual to treat with a given therapeutic or preventive intervention. Before being tested in large field studies and recommended for clinical adoption, it is important to evaluate not only their statistical accuracy but also the impact they may have when used to inform health intervention policies. We aim to provide simple methods for the potential impact assessment of health intervention policies based on predictive models.

Methods: We propose an analytic framework based on Qini curves wherein prediction-based policies are analyzed on 2 impact endpoints: (1) the fraction of the population that would be selected for the intervention (coverage) and (2) the effect on the clinical outcomes of interest (disutility). The drivers of values are the disease prevalence, the predictive performance of the model, and the effectiveness of the intervention.

Results: We present simple formulas for calculating coverage and disutility from either observational or randomized controlled data. We illustrate possible value measures arising from geometrical properties on the Qini plane: delta coverage and disutility, number needed to treat, and integrated difference between Qini curves. We show the applicability of the Qini analysis by providing examples about the prevention of falls in older adults and prevention of secondary cardiovascular events with pioglitazone.

Conclusions: Coverage and disutility capture key value components of prediction-based policies. The method can be used for comparing models or tuning risk thresholds for managing trade-offs between conflicting objectives (eg, clinical benefits, side effects, and healthcare resources).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
为干预政策提供信息的风险预测模型潜在影响评估的基尼曲线。
目的:医学上的预测模型有助于决定用给定的治疗或预防干预措施治疗哪个个体。在大规模实地研究中进行测试并建议临床采用之前,重要的是不仅要评估其统计准确性,而且要评估它们在为卫生干预政策提供信息时可能产生的影响。我们的目标是为基于预测模型的卫生干预政策的潜在影响评估提供简单的方法。方法:我们提出了一个基于基尼曲线的分析框架,其中基于预测的政策在两个影响终点上进行分析:i)将被选择进行干预的人口比例(覆盖率)和ii)对感兴趣的临床结果的影响(负效用)。价值的驱动因素是疾病的流行程度、模型的预测性能和干预的有效性。结果:我们提出了简单的公式来计算观察数据或随机对照数据的覆盖率和负效用。我们举例说明了从Qini平面上的几何性质产生的可能的价值度量:delta覆盖和负效用,需要处理的数量,以及Qini曲线之间的综合差异。我们通过提供吡格列酮预防老年人跌倒和预防继发性心血管事件的例子来证明Qini分析的适用性。结论:覆盖率和负效用捕获了基于预测的政策的关键价值组成部分。该方法可用于比较模型或调整风险阈值,以管理相互冲突的目标之间的权衡(例如,临床益处、副作用和医疗资源)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Value in Health
Value in Health 医学-卫生保健
CiteScore
6.90
自引率
6.70%
发文量
3064
审稿时长
3-8 weeks
期刊介绍: Value in Health contains original research articles for pharmacoeconomics, health economics, and outcomes research (clinical, economic, and patient-reported outcomes/preference-based research), as well as conceptual and health policy articles that provide valuable information for health care decision-makers as well as the research community. As the official journal of ISPOR, Value in Health provides a forum for researchers, as well as health care decision-makers to translate outcomes research into health care decisions.
期刊最新文献
Fast Science, Slow Evaluation: What Makes Health Technology Assessment of Genetic and Genomic Technologies So Complicated? A Systematic Review of Methodological Challenges and Identified Suggestions. Designing and Implementing Real World Patient Reported Outcomes (RW- PROs) - Emerging Recommendations: A Good Practices Report of an ISPOR Task Force. Development of the Medical Device Economic Evaluation Methodological Quality (DEEM-Q) Checklist. Informing the US Medicare drug price negotiation for Trelegy Ellipta and Breo Ellipta: Evaluating the impact of real-world evidence. Health economic evaluations alongside adaptive platform trials: A systematic review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1